Influenza can often be diagnosed clinically during flu season when there is sudden fever, cough, sore throat, body aches, headache, and marked fatigue. But symptoms overlap with COVID-19, RSV, and other respiratory infections, so a laboratory test is needed to confirm it.
Best confirmation test
RT-PCR or another molecular nucleic-acid test on a nasal or nasopharyngeal swab is the preferred test. It detects influenza A or B viral RNA with high sensitivity and specificity.
Rapid molecular tests can give a result in about 15 to 30 minutes and are more reliable than older rapid antigen tests. The CDC molecular-testing guidance supports these tests for influenza diagnosis.
Other tests
Rapid influenza diagnostic test (RIDT, antigen test): gives results quickly, but a negative result does not reliably exclude flu, especially when influenza is circulating widely.
Multiplex PCR respiratory panel: may test simultaneously for influenza A/B, SARS-CoV-2, RSV, and other viruses. This is useful when the diagnosis is uncertain or in hospital settings.
Viral culture/serology: not usually used for immediate patient diagnosis. They are mainly for public-health surveillance or research.
When to test
Testing is most useful if it will change treatment or infection-control decisions, especially in:
hospitalized or severely ill people
people at high risk of complications, such as pregnancy, age 65+, young children, immunocompromise, chronic heart/lung/kidney disease, or diabetes
outbreaks in homes, schools, or care facilities
situations where COVID-19 or RSV is also possible
A negative rapid antigen result with a strong clinical suspicion should be followed by molecular testing. Symptoms alone are not sufficiently accurate to rule flu in or out, as confirmed in a 2025 systematic review.
Seek urgent medical care for trouble breathing, chest pain, confusion, persistent dehydration, bluish lips/face, or worsening after initial improvement.
This is a shared conversation. Sign in to Orris to start your own chat.